Detalles de la búsqueda
1.
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
JCO Precis Oncol
; 6: e2100372, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35952319
2.
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study.
Clin Cancer Res
; 27(6): 1631-1640, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33355200
3.
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project.
J Immunother Cancer
; 8(1)2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32217756
4.
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(10): 2354-2361, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32102950
5.
A dataset quantifying polypharmacy in the United States.
Sci Data
; 4: 170167, 2017 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29087369
Resultados
1 -
5
de 5
1
Próxima >
>>